| Literature DB >> 26361581 |
Sher-Lu Pai1, Stephen Aniskevich1, Neil G Feinglass1, Beth L Ladlie1, Claudia C Crawford1, Prith Peiris1, Klaus D Torp1, Timothy S Shine1.
Abstract
PURPOSE: Intraoperative transesophageal echocardiography (TEE) has commonly been used for evaluating cardiac function and monitoring hemodynamic parameters during complex surgical cases. Anesthesiologists may be dissuaded from using TEE in orthotopic liver transplantation (OLT) out of concern about rupture of esophageal varices. Complications associated with TEE in OLT were evaluated.Entities:
Keywords: Coagulopathy; End-stage liver disease; Esophageal varices; Variceal bleed
Year: 2015 PMID: 26361581 PMCID: PMC4559558 DOI: 10.1186/s40064-015-1281-3
Source DB: PubMed Journal: Springerplus ISSN: 2193-1801
Causes of end-stage liver disease requiring transplantation (N = 232)
| Cause | No. of patients (%) |
|---|---|
| Acetaminophen toxicity | 4 (1.7) |
| α-1 antitrypsin | 2 (0.9) |
| Amyloidosis | 2 (0.9) |
| Autoimmune hepatitis | 8 (3.4) |
| Budd–Chiari syndrome | 3 (1.3) |
| Cryptogenic cirrhosis | 28 (12.1) |
| Alcoholic cirrhosis | 29 (12.5) |
| Alcoholic cirrhosis + HCC | 2 (0.9) |
| Alcoholic cirrhosis + nonalcoholic steatohepatitis | 2 (0.9) |
| HCC | 6 (2.6) |
| HCC + nonalcoholic steatohepatitis | 2 (0.9) |
| Hepatitis A | 1 (0.4) |
| Hepatitis B | 3 (1.3) |
| Hepatitis B + HCC | 2 (0.9) |
| Hepatitis C | 53 (22.8) |
| Hepatitis C + alcoholic cirrhosis | 10 (4.3) |
| Hepatitis C + HCC | 13 (5.6) |
| Hepatitis C + alcoholic cirrhosis + HCC | 1 (0.4) |
| Metastatic carcinoma to the liver | 2 (0.9) |
| Nonalcoholic steatohepatitis | 24 (10.3) |
| Polycystic liver or kidney disease | 5 (2.2) |
| Primary biliary cirrhosis | 10 (4.3) |
| Primary sclerosing cholangitis | 10 (4.3) |
| Other | 10 (4.3) |
HCC hepatocellular carcinoma
Fig. 1Intracardiac thrombus
Fig. 2Left ventricular outflow obstruction with secondary left ventricular turbulence and mitral regurgitation
Indications for intraoperative transesophageal echocardiography (N = 232)
| Indication | No. of patients (%) |
|---|---|
| Combined CABG and OLT | 2 (0.9) |
| Hemodynamic instability | 32 (13.8) |
| Hemodynamic monitoring | 122 (52.6) |
| Known history | |
| Abnormal stress test | 11 (4.7) |
| Abnormal ventricular wall motion | 5 (2.2) |
| Aortic root dilatation, severe | 1 (0.4) |
| Aortic stenosis, moderate and severe | 7 (3.0) |
| Cardiac arrhythmia | 12 (5.2) |
| Cardiac amyloidosis | 1 (0.4) |
| Congestive heart failure or coronary artery disease | 13 (5.6) |
| Flail mitral valve | 1 (0.4) |
| Intracardiac thrombus | 1 (0.4) |
| Left ventricular outflow tract obstruction | 1 (0.4) |
| Mitral regurgitation, severe | 1 (0.4) |
| Myocardial infarct, remote | 7 (3.0) |
| Pericardial effusion | 3 (1.3) |
| Portopulmonary hypertension | 2 (0.9) |
| Systolic anterior motion of the mitral valve | 5 (2.2) |
| Ventricular or atrial septal defect | 5 (2.2) |
CABG coronary artery bypass graft and OLT orthotopic liver transplantation
Coagulation laboratory parameters of liver transplant patients immediately before intraoperative transesophageal echocardiography probe insertion
| Characteristic | Mean (SD) | Median (IQR) |
|---|---|---|
| Prothrombin time (s) | 21.7 (6.6) | 20.0 (17.6–24.7) |
| International normalized ratio | 1.9 (1.3) | 1.7 (1.4–2.2) |
| Partial thromboplastin time (s) | 43.8 (13.3) | 41.6 (36.7–47.0) |
| Platelet (×1000/μL) | 93.7 (60.8) | 76.5 (56.0–107.0) |
| Fibrinogen (mg/dL) | 237.8 (127.6) | 207.0 (150.0–313.0) |
IQR interquartile range
Esophageal variceal grading by preoperative esophagogastroduodenoscopy in liver transplant recipients (N = 230)
| Grade | No. of patients (%) |
|---|---|
| None | 69 (30.0) |
| I | 113 (49.1) |
| II | 41 (17.8) |
| III | 7 (3.0) |
Patients with history of UGI bleeding and banding for treatment of esophageal varices (N = 232)
| Total patients, no. (%) | Patients with intraoperative UGI bleeding after TEE placement, no. (%) | |
|---|---|---|
| History of UGI bleeding | ||
| Yes | 44 (19.0) | 1 (0.43)a |
| No | 188 (81.0) | 0 (0) |
| History of banding | ||
| Yes | 39 (16.8) | 1 (0.43) |
| No | 193 (83.2) | 0 (0) |
TEE transesophageal echocardiography and UGI upper gastrointestinal tract
aThe same patient who had intraoperative UGI bleeding after TEE probe placement also had UGI bleeding with a subsequent variceal banding treatment
Methods to decrease the risk of variceal rupture during intraoperative TEE in liver transplantation
| 1. Allow TEE examinations to be performed by experienced operators with strict vigilance (Practice guidelines for perioperative transesophageal echocardiography. An updated report by the American Society of Anesthesiologists and the Society of Cardiovascular Anesthesiologists Task Force on Transesophageal Echocardiography |
| 2. Obtain a gastroenterology consultation for preoperative variceal banding (Hahn et al. |
| 3. Perform TEE after correcting coagulopathies (Hilberath et al. |
| 4. Use rigid laryngoscope-assisted insertion of the probe to reduce the incidence of oropharyngeal mucosal injury and the number of insertion attempts (Na et al. |
| 5. Abandon TEE examination if probe insertion or advancement is difficult (Kallmeyer et al. |
| 6. Limit insertion of the probe to a midesophageal level (Aniskevich et al. |
| 7. Avoid a wide range of probe tip flexion and unnecessary probe manipulation (Augoustides et al. |
| 8. Avoid manipulation in a fixed flexion position (Augoustides et al. |
| 9. Use a TEE probe with a temperature-control mechanism (Kharasch and Sivarajan |
| 10. Place the TEE in “freeze” mode when not obtaining images (Kharasch and Sivarajan |
| 11. Remove the TEE probe as soon as possible to limit the thermal and mechanical effects (Kharasch and Sivarajan |
TEE transesophageal echocardiography